Ro KhannaSell
IQV Common Stock · Transaction Jun 30, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · IQV
+2.70% · +$6.27 · Vol 1.1M
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
IQVIA Holdings Inc
Life Sciences Tools & Services
$238.70
Veridion Score
BETAHIGH CONF · 6/6 factorsFri Aug 7 · last completed session · Markets closed · resumes Mon 9:30 ET · IQV
MethodologyIQV
IQVIA Holdings Inc
Fri Aug 7 · last completed session · Markets closed · resumes Mon 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
70/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 7 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is IQV moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About IQVIA Holdings Inc
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHListed since
2013
Employees
94K
Country
US
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$232.41
Day high
$238.78
Day low
$230.50
Previous close
$232.43
52W high
$247.56
-3.58% from high
52W low
$156.66
90% of range
Market cap
$39.3B
P/E
36.11×
EPS
$6.61
Beta
0.11
Shares out
164.6M
Volume
1.1M
0.74× rel vol
Avg volume
1.5M
VWAP
$237.26
Price history computed in-house
1W
+1.57%
1M
+14.84%
3M
+37.54%
1Y
+32.71%
YTD
+5.90%
SMA 50 $200.62 · above
SMA 200 $198.15 · above
52W position 90%
IQV overview
Related filings and maps
Public disclosures
Congress activity in IQV
Official filing ↗
Ro KhannaSell
IQV Common Stock · Transaction Jun 2, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
Ro KhannaSell
IQV Common Stock · Transaction May 27, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
Ro KhannaBuy
IQV Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
Ro KhannaSell
IQV Common Stock · Transaction Apr 13, 2026 · Filed May 11, 2026 · Amount pending receipt enrichment
Federal contracts
IQV contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IQV in this window.
Lobbying spend
IQV lobbying filings, year to date.
Registered lobbying filings matched to IQVIA Holdings Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IQV in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for IQV.
Options
Sovereign unlock shows live options positioning for IQV.